Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial Cancer
- Status
- COMPLETED
- Phase
- N/A
Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE3
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Tezepelumab COPD Exacerbation Study
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life
- Status
- COMPLETED
- Phase
- N/A
Treatment Patterns, Outcomes and Testing in EGFRm NSCLC Patients With EGFR TKI 1L Across Europe (REFLECT)
- Status
- COMPLETED
- Phase
- N/A
Genomic BRCA and Extensive ovArian Cancer Testing
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Relative Bioavailability of 3 Different Formulations Under Fasted and Fed Condition
- Status
- COMPLETED
- Phase
- PHASE1
Stage III NSCLC RWE in Chinese Patients
- Status
- COMPLETED
- Phase
- N/A
AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)
- Status
- COMPLETED
- Phase
- PHASE2
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mass Balance Recovery, Pharmacokinetics and Metabolite Profile and Identification of [14C]AZD7594
- Status
- COMPLETED
- Phase
- PHASE1
Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
- Status
- WITHDRAWN
- Phase
- PHASE1
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC
- Status
- COMPLETED
- Phase
- N/A